Your browser doesn't support javascript.
loading
Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain.
Cullell, Natalia; Carrera, Caty; Muiño, Elena; Torres-Aguila, Nuria-Paz; Cárcel-Márquez, Jara; González-Sánchez, Jonathan; Gallego-Fabrega, Cristina; Molina, Jessica; Besora, Sarah; Sotoca, Javier; Buongiorno, Maria-Teresa; Jiménez-Conde, Jordi; Giralt-Steinhauer, Eva; de Torres-Chacón, Reyes; Montaner, Joan; Mancha, Fernando; Cabezas, Juan A; Martí-Fàbregas, Joan; Prats-Sánchez, Luis; Camps-Renom, Pol; Purroy, Francisco; Cambray, Serafi; Freijo, María Del Mar; Vives-Bauzá, Cristòfol; Tur, Silvia; Font, Maria-Àngels; López-Cancio, Elena; Hernandez-Perez, Maria; Obach, Victor; Calleja, Ana; Arenillas, Juan; Rodríguez-Yáñez, Manuel; Castillo, José; Sobrino, Tomas; Fernández-Cádenas, Israel; Krupinski, Jerzy.
Afiliação
  • Cullell N; Neurology, Hospital Universitari MútuaTerrassa/Fundacio Docència i Recerca MútuaTerrassa, Terrassa, Spain.
  • Carrera C; Stroke Pharmacogenomics and Genetics, Biomedical Research Institute Sant Pau, Barcelona, Spain.
  • Muiño E; Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.
  • Torres-Aguila NP; Stroke Pharmacogenomics and Genetics, Biomedical Research Institute Sant Pau, Barcelona, Spain.
  • Cárcel-Márquez J; Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.
  • González-Sánchez J; Stroke Pharmacogenomics and Genetics, Biomedical Research Institute Sant Pau, Barcelona, Spain.
  • Gallego-Fabrega C; Stroke Pharmacogenomics and Genetics, Biomedical Research Institute Sant Pau, Barcelona, Spain.
  • Molina J; Stroke Pharmacogenomics and Genetics, Biomedical Research Institute Sant Pau, Barcelona, Spain.
  • Besora S; Neurology, Hospital Universitari MútuaTerrassa/Fundacio Docència i Recerca MútuaTerrassa, Terrassa, Spain.
  • Sotoca J; Centre for bioscience, School of HealthCare Science, Manchester Metropolitan University, Manchester, UK.
  • Buongiorno MT; Neurology, Hospital Universitari MútuaTerrassa/Fundacio Docència i Recerca MútuaTerrassa, Terrassa, Spain.
  • Jiménez-Conde J; Stroke Pharmacogenomics and Genetics, Biomedical Research Institute Sant Pau, Barcelona, Spain.
  • Giralt-Steinhauer E; Neurology, Hospital Universitari MútuaTerrassa/Fundacio Docència i Recerca MútuaTerrassa, Terrassa, Spain.
  • de Torres-Chacón R; Neurology, Hospital Universitari MútuaTerrassa/Fundacio Docència i Recerca MútuaTerrassa, Terrassa, Spain.
  • Montaner J; Neurology, Hospital Universitari MútuaTerrassa/Fundacio Docència i Recerca MútuaTerrassa, Terrassa, Spain.
  • Mancha F; Neurology, Hospital Universitari MútuaTerrassa/Fundacio Docència i Recerca MútuaTerrassa, Terrassa, Spain.
  • Cabezas JA; Neurology, Hospital del Mar Medical Research Institute, Barcelona, Spain.
  • Martí-Fàbregas J; Neurology, Hospital del Mar Medical Research Institute, Barcelona, Spain.
  • Prats-Sánchez L; Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Camps-Renom P; Institute de Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville & Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Purroy F; Institute de Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville & Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Cambray S; Institute de Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville & Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Freijo MDM; Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Vives-Bauzá C; Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Tur S; Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Font MÀ; Stroke Unit, Department of Neurology, Universitat de Lleida, Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain.
  • López-Cancio E; Clinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), Universitat de Lleida, Lleida, Spain.
  • Hernandez-Perez M; Neurology, Basurto Hospital, Bilbao, Spain.
  • Obach V; Neurobiology Laboratory, Research Unit, Son Espases University Hospital, Illes Balears, Spain.
  • Calleja A; Neurology, Son Espases University Hospital, Illes Balears, Spain.
  • Arenillas J; Neurology, Moisès Broggi Hospital, Barcelona, Spain.
  • Rodríguez-Yáñez M; Stroke Unit, Germans Trias i Pujol Hospital, Barcelona, Spain.
  • Castillo J; Stroke Unit, Hospital Universitario Central de Asturias, Asturias, Spain.
  • Sobrino T; Stroke Unit, Germans Trias i Pujol Hospital, Barcelona, Spain.
  • Fernández-Cádenas I; Neurology, Hospital Clinic, Barcelona, Spain.
  • Krupinski J; Department of Neurology, University Clinical Hospital of Valladolid, Valladolid, Spain.
Sci Rep ; 10(1): 2806, 2020 02 18.
Article em En | MEDLINE | ID: mdl-32071341
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Vitamina K Epóxido Redutases / Citocromo P-450 CYP2C9 / Acenocumarol / Anticoagulantes Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Vitamina K Epóxido Redutases / Citocromo P-450 CYP2C9 / Acenocumarol / Anticoagulantes Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article